Diagnosis and management of diastolic dysfunction and heart failure

American Family Physician

Volumn 73, Issue 5, 2006, Pages 841-846

  Satpathy, Chhabi ^a,c   Mishra, Trinath K ^a,c   Satpathy, Ruby ^b   Satpathy, Hemant K ^b,d   Barone, Eugene ^b  

^a Sriram Chandra Bhanja Medical College   (India)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c UTKAL UNIVERSITY   (India)

^d SCB Medical College ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; VASODILATOR AGENT;

BLOOD PRESSURE REGULATION; BLOOD VOLUME; CARDIOMYOPATHY; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIURETIC ACTIVITY; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEPATOMEGALY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LUNG CIRCULATION; PREVALENCE; PROGNOSIS; REVIEW; SALT INTAKE; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

EID: 33644761969     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Tecce MA, Pennington JA, Segal BL, Jessup ML. Heart failure: clinical implications of systolic and diastolic dysfunction. Geriatrics 1999;54:24-8,31-3.
2. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12.
3. Litwin SE, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol 1993;22(4 suppl A):49A-55A.
4. Brutsaert DL, Sys SU. Diastolic dysfunction in heart failure. J Card Fail 1997;3:225-42.
5. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
6. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001;38:1277-82.
7. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure: pathophysiology and therapeutic implications [published correction appears in J Am Coll Cardiol 1993;22:1272]. J Am Coll Cardiol 1993;22:318-25.
8. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
9. Grossman W. Defining diastolic dysfunction. Circulation 2000;101:2020-1.
10. van Kraaij DJ, van Pol PE, Ruiters AW, de Swart JB, Lips DJ, Lencer N, et al. Diagnosing diastolic heart failure. Eur J Heart Fail 2002;4:419-30.
11. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.
12. Kitzman DW, Gardin JM, Arnold A, Gottdiener JS, Lyles M, Smith VE, et al., for the CHS Research Group. Heart failure with preserved systolic LV function in the elderly: clinical and echocardiographic correlates from the Cardiovascular Health Study. Circulation 1996;94(suppl 1):1-433.
13. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
14. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9.
15. Ahmed A, Nanda NC, Weaver MT, Allman RM, DeLong JF. Clinical correlates of isolated left ventricular diastolic dysfunction among hospitalized older heart failure patients. Am J Geriatr Cardiol 2003;12:82-9.
16. Kovacs SJ, Meisner JS, Yellin EL. Modeling of diastole [published correction appears in Cardiol Clin 2000;18:following table of contents]. Cardiol Clin 2000;18:459-87.
17. Mandinov L, Eberli FR, Seiler C, Hess OM. Diastolic heart failure. Cardiovasc Res 2000;45:822.
18. Philbin EF, Hunsberger S, Garg R, Lader E, Thadani U, McSherry F, et al, and the Digitalis Investigation Group. Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol 2002;89:1218-21.
19. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003;41:2010-7.
20. Naqvi TZ. Diastolic function assessment incorporating new techniques in Doppler echocardiography. Rev Cardiovasc Med 2003;4:81-99.
21. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-40.
22. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001;38:2101-13.
23. Chen HH, Lainchbury JB, Senni M, Redfield MM. Factors influencing survival in patients with diastolic heart failure in Olmsted County, Minn. Circulation 2000;102:II412.
24. Angomachalelis N, Hourzamanis AI, Sideri S, Serasli E, Vamvalis C. Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection. Heart Vessels 1996;11:303-9.
25. Mitsunami K, Inoue S, Maeda K, Endoh S, Takahashi M, Okada M, et al. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 1998;12:469-74.
26. Warner JG Jr, Metzger DC, Kitzman DW, Wesley DJ, Little WC. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999;33:1567-72.
27. Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-13.
28. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.
29. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al., for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
30. Gutierrez C, Blanchard DG. Diastolic heart failure: challenges of diagnosis and treatment. Am Fam Physician 2004;69:2609-16.
31. Cohn JN, Johnson G, for the Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT Study. Circulation 1990;81(2 suppl):III48-53.
32. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.